Stay updated with breaking news from Nyse Zyme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the sale, the insider now directly owns 7,367 shares of […]
683 Capital Management LLC lowered its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 65.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,900 shares of the company’s stock after selling 125,100 shares during […]
683 Capital Management LLC lessened its position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 65.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 64,900 shares of the company’s stock after selling 125,100 shares during the period. […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report)’s share price shot up 3.8% on Monday . The company traded as high as $8.47 and last traded at $8.45. 118,028 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 568,921 shares. The stock had previously closed at $8.14. Wall Street […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given an average rating of “Hold” by the seven brokerages that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective […]